Related Experiment Video
Updated: May 17, 2026

MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as a Novel Detection and Quantification Method
Published on: October 7, 2025
The role and clinical implications of microRNAs in hepatocellular carcinoma
Xue Zhao1, Zhen Yang, Guangbing Li
1Department of Liver Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100005, China.
Abstract:
Hepatocellular carcinoma (HCC) is common and one of the most aggressive of all human cancers. Recent studies have indicated that miRNAs, a class of small noncoding RNAs that regulate gene expression post-transcriptionally, directly contribute to HCC by targeting many critical regulatory genes. Several miRNAs are involved in hepatitis B or hepatitis C virus replication and virus-induced changes, whereas others participate in multiple intracellular signaling pathways that modulate apoptosis, cell cycle checkpoints, and growth-factor-stimulated responses. When disturbed, these pathways appear to result in malignant transformation and ultimately HCC development. Recently, miRNAs circulating in the blood have acted as possible early diagnostic markers for HCC. These miRNA also could serve as indicators with respect to drug efficacy and be prognostic in HCC patients. Such biomarkers would assist stratification of HCC patients and help direct personalized therapy. Here, we summarize recent advances regarding the role of miRNAs in HCC development and progression. Our expectation is that these and ongoing studies will contribute to the understanding of the multiple roles of these small noncoding RNAs in liver tumorigenesis.
Insights
MicroRNAs (miRNAs) are small noncoding RNAs crucial in hepatocellular carcinoma (HCC) development. Circulating miRNAs show promise as early diagnostic markers and prognostic indicators for personalized HCC therapy.
Area of Science:
- Molecular Biology
- Oncology
- Biochemistry
Background:
- Hepatocellular carcinoma (HCC) is an aggressive cancer with complex molecular underpinnings.
- MicroRNAs (miRNAs), small noncoding RNAs regulating gene expression, are implicated in HCC pathogenesis.
- Dysregulation of miRNA-controlled pathways, including apoptosis and cell cycle, contributes to liver tumorigenesis.
Purpose of the Study:
- To review the current understanding of miRNA roles in HCC development and progression.
- To highlight the potential of miRNAs as diagnostic and prognostic biomarkers for HCC.
- To discuss the implications of miRNAs in guiding personalized HCC treatment strategies.
Main Methods:
- Literature review of recent studies on miRNAs in HCC.
- Analysis of miRNA involvement in viral hepatitis and intracellular signaling pathways.
- Examination of circulating miRNAs as potential biomarkers.
Main Results:
- miRNAs directly target critical genes involved in HCC.
- Specific miRNAs are associated with hepatitis B/C virus replication and oncogenic signaling.
- Circulating miRNAs are emerging as sensitive and specific biomarkers for early HCC detection, drug efficacy, and prognosis.
Conclusions:
- miRNAs play multifaceted roles in liver cancer initiation and advancement.
- Circulating miRNAs offer a non-invasive approach for HCC diagnosis and patient stratification.
- Further research into miRNAs will enhance understanding and facilitate targeted therapies for HCC.
Related Concept Videos
MicroRNAs
MicroRNAs
MicroRNAs
lncRNA - Long Non-coding RNAs

